Warren Buffett has distanced himself from Berkshire Hathaway's investment in Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA). Speaking to "CNBC," he punctured the notion that the "Oracle from Omaha" saw some special hidden value in the Israeli pharmaceutical company, or was planning to link it to the healthcare venture he has set up with Jeff Bezos and Jamie Dimon. RELATED ARTICLES Cramer shocked by Buffett's investment in "second-rate" Teva Buffett boosts Teva with $358m investment Outrage as Teva charges $18,275 for generic drug in US Kare Schultz buys time for Teva and himself Earlier this month it was revealed that Berkshire Hathaway, controlled by Buffett, had acquired 18.9 million shares of Teva during the fourth quarter, giving it a 1.8% stake in the troubled Israeli drugmaker for a total investment of $358 million. The news sent Teva's share price soaring. But in the "CNBC" interview, Buffett made it clear that he had no idea why the position was taken. He said that one of his investment deputies bought Teva and the investment deputy didn't tell him and won't if he sells it. Teva's share price is down 2.15% on the NYSE, giving a market cap of $19.94 billion. Published by Globes [online], Israel business news - www.globes-online.com - on February 26, 2018 © Copyright of Globes Publisher Itonut (1983) Ltd. 2018
